Drug Court Regulation 2020

The Regulation repeatedly operationalises a small set of core concepts from the Drug Court Act 1998 and related instruments. The Act is identified in the Regulation as "the Act" (s 3(1)), and the Regulation supplies precise procedural scaffolding for how the Drug Court component of the criminal justice system functions.

Key definitional concept: facsimile. The Regulation defines facsimile to include traditional facsimile transmission, the Internet and other electronic transmissions where written material can be reproduced with or without additional devices (s 3(1)). The effect is to broaden accepted modes of document transmission and to treat certain electronic methods as equivalent to facsimile in the Regulation’s operational rules. That definition is relevant across provisions that permit facsimile as a method for giving notices, referrals and other communications (for example s 10(2)(a); s 13; s 14(2)).

Eligibility. The Regulation prescribes two related but distinct categories of eligibility drawn from the Act: "eligible person" for referral during proceedings (s 4), and "eligible convicted offender" for referral following conviction (s 5). Each category contains multiple threshold criteria. Both include geographic residence or capacity to reside within named local government areas (s 4(a); s 5(a)). Both require adult age (18 years or over) and exclusion of matters within the Children’s Court jurisdiction (s 4(c)-(d); s 5(b)-(c)). The eligible convicted offender category in s 5 also includes a sex‑based criterion, requiring the person to be male (s 5(d)). The lists of local government areas differ between s 4 and s 5; practitioners must compare the lists when assessing a person’s eligibility for either pathway.

Referrals and referring courts. The Regulation prescribes which courts may refer matters to the Drug Court depending on the context. For referrals during proceedings the Local Court and District Court are prescribed (s 6). For referrals of eligible convicted offenders the list expands to include the Drug Court itself for certain sentences and the Court of Criminal Appeal for particular appeals (s 9). The Regulation also sets the communication modalities for making a referral to the Drug Court (s 13).

Facilities and allocation. The Regulation sets minimum conditions for a facility to be considered available (provider willingness, reasonable likelihood of availability at the time needed, and registrar receipt of advice about the proposed treatment) and expressly leaves allocation of facilities to policies determined by the Drug Court (s 7(1)(a)-(b)). This creates a two‑step mechanism: objective availability criteria and discretionary allocation under court‑determined policy.

Modification of procedural obligation. The Regulation modifies the operation of section 265(1) and (2) of the Criminal Procedure Act 1986 in Drug Court proceedings under certain sections of the Act. The modification suspends the obligations of the Drug Court and the prosecutor under those Criminal Procedure Act provisions if the person charged consents (s 8(1)). The Regulation lists events that will end that suspension (s 8(2)(a)-(d)).

Information sharing. The Regulation prescribes who may supply information to the Drug Court in the context of a drug offender’s program,specific local health district personnel, the Drug Toxicology Unit of NSW Forensic and Analytical Science Service, and organisations providing treatment to a drug offender for the program,subject to the condition that they are involved in administration or service delivery for the program (s 10(1)). It prescribes permitted methods for providing information to the registrar and requires written confirmation within 24 hours for information supplied otherwise than in writing unless the registrar indicates otherwise (s 10(2)).

Forms and fees. The Regulation allows use of District Court and Local Court forms and fees in the Drug Court when it exercises the criminal jurisdiction of the respective court (s 11; s 12(1)). The Drug Court or the registrar may postpone, waive or remit any fee that the Act permits (s 12(2)-(3)).

Communications and procedural mechanics. The Regulation sets operational rules for referral notice (s 13), for the Drug Court referring matters back to referring courts including in the absence of the person (s 14(1)), and for the registrar to notify a court by telephone or facsimile of a referral back (s 14(2)).

Savings and continuity. A savings provision preserves acts, matters and things that had effect under the repealed 2015 Regulation to continue under this Regulation (s 15).

These core concepts together create a procedural architecture that links eligibility thresholds, geographic constraints, administrative duties, information flows, adjudicative discretions and communication modes. The Regulation therefore functions as a practical manual for how the Drug Court’s cases are to be channelled, documented and supported by treatment and health services, and how certain criminal procedure obligations may be paused with a charged person’s consent.

The Regulation names several discrete groups and public bodies as directly affected, and others as indirectly affected by changed administrative practice.

Listed persons who are the Regulation’s primary subjects:

• Individuals charged with offences who might be referred to the Drug Court. Their eligibility for referral during proceedings is constrained by criteria in s 4: their usual residence must be within a prescribed list of local government areas, they must be at least 18, they must not have a mental condition preventing active participation in a program, and their matter must not fall within the Children’s Court jurisdiction (s 4(a)-(d)). Persons charged therefore must be assessed against these thresholds by defence counsel, court staff and the prosecutor.
• Convicted offenders who might be referred post‑conviction. The Regulation prescribes differing eligibility conditions for eligible convicted offenders, including residence or capacity to reside within a listed set of local government areas, age 18 or over, exclusion of matters within the Children’s Court, and a requirement that the person be male (s 5(a)-(d)). This sex requirement directly affects which convicted persons can be dealt with under the eligible convicted offender pathway.

Courts and court officials:

• The Local Court and the District Court are prescribed as referring courts for referrals during proceedings (s 6). For referrals of eligible convicted offenders, the list includes the District Court, Local Court, the Drug Court itself for certain sentences, and the Court of Criminal Appeal for appeals from those courts (s 9(a)-(d)). Judicial officers and registrars in these courts will regularly apply the Regulation’s referral and notification rules (s 13; s 14).

The registrar of the Drug Court:

• The registrar is a central administrative actor under the Regulation. The registrar receives information from treatment providers and health district personnel (s 10(1)-(2)), may be the person through whom the Drug Court exercises fee waiver or remission functions (s 12(3)), and is the addressee for referral notices and notifications (s 13; s 14(2)). The registrar’s role includes confirming oral information in writing within 24 hours unless otherwise indicated (s 10(2)(b)).

Health and treatment providers:

• Persons acting for or on behalf of specified local health districts, the Drug Toxicology Unit of the NSW Forensic and Analytical Science Service, and organisations providing treatment to a drug offender in relation to the offender’s program are prescribed as permitted sources of information for the Drug Court (s 10(1)(a)-(c)). Their participation in administration or service delivery under a drug offender’s program brings them within obligations to communicate with the registrar and to confirm oral communications as required (s 10(2)).

Prosecutors and defence representatives:

• The Regulation modifies prosecution and court obligations under the Criminal Procedure Act in defined Drug Court proceedings where a charged person consents to the suspension (s 8(1)). This affects how prosecutors and defence counsel manage consent, disclosure and other procedural steps in those proceedings.

Other affected groups and operational consequences:

• Providers of accommodation or treatment facilities used for supervision and control of a referred person are affected by the Regulation’s availability criteria: they must be willing to accept referred persons and the registrar must receive advice as to the proposed treatment (s 7(1)(a)(i) and (iii)). Allocation of such facilities is subject to Drug Court policy (s 7(1)(b)).
• Persons who might be required to pay court fees in the Drug Court will be affected by s 12, which permits fee charging as in District/Local Courts but allows postponement, waiver or remission by the Drug Court or registrar.

Indirect effects:

• Geographic lists in s 4 and s 5 mean that persons living outside the specified local government areas are not eligible under those prescribed criteria, which will affect defence strategies, plea discussions, sentencing options and the flow of cases into the Drug Court system. The divergent lists between s 4 and s 5 mean different cohorts are eligible in the pre‑conviction and post‑conviction pathways.

In short, the Regulation directly affects charged persons and convicted offenders who meet or fail to meet the specified eligibility thresholds, courts that make referrals or receive referrals back, registrars who manage information and fees, health and treatment organisations involved in program delivery, and legal representatives who must advise clients about procedural consequences of consent under s 8. The concrete channel for many of these effects is the registrar and the Drug Court’s policy on facility allocation (s 7; s 10; s 12).

The Regulation allocates specific duties to courts, the Drug Court, the registrar, treatment providers and particular health agencies, and it creates rights and procedural options for charged persons and convicted offenders. The provisions below set out the principal duties and rights created or clarified by the Regulation.

Registrar duties and powers:

• Receipt and confirmation: persons authorised under s 10(1) may provide information to the registrar in specified ways; if information is supplied orally it must be confirmed in writing within 24 hours unless the registrar indicates otherwise (s 10(2)(a)-(b)). This places a duty on those persons to confirm oral communications and a correlative power on the registrar to require or waive the confirmation requirement.
• Fee remission and waiver: the registrar may exercise the Drug Court’s function to postpone, waive or remit fees under the Act, either unconditionally or subject to conditions (s 12(2)-(3)). This vests discretionary financial relief power with the registrar as well as the court.
• Communications: the registrar is the recipient of referral notifications and treatment advice for facility availability (s 7(1)(a)(iii); s 13).

Drug Court duties and powers:

• Facility allocation policies: facilities are to be allocated to referred persons according to policies determined from time to time by the Drug Court (s 7(1)(b)). The Drug Court therefore has a policy‑making duty to decide allocation criteria and a power to implement them.
• Referral back: the Drug Court may order that a matter be referred back to the referring court under section 7D of the Act and can do so in the absence of the person to whom the order relates (s 14(1)). The Drug Court also may postpone, waive or remit fees (s 12(2)).

Court duties:

• Referring courts have a duty to use the prescribed channels for referral to the Drug Court: notification to the registrar by telephone, in writing or by facsimile (s 13). The Local Court and District Court are prescribed as referring courts for referrals during proceedings (s 6).

Health and treatment provider duties:

• Persons acting for or on behalf of specified local health districts, the Drug Toxicology Unit, or organisations providing treatment in connection with a drug offender’s program are prescribed persons for the purposes of supplying information to the Drug Court (s 10(1)(a)-(c)). They must provide information by permitted methods and confirm oral communications within the time limit unless the registrar indicates otherwise (s 10(2)). The Regulation therefore places operational obligations on these entities whenever they are involved in the administration of, or provide services in connection with, a drug offender’s program.

Rights and options for charged persons and convicted offenders:

• Consent to suspension: a charged person has the right to consent to the suspension of the obligations of the Drug Court and the prosecutor under specified provisions of the Criminal Procedure Act 1986 in proceedings before the Drug Court under sections 7A, 7B or 7C of the Act. The suspension applies only if the person consents (s 8(1)). Consent is therefore a procedural option available to the charged person.
• Withdrawal of consent and cessation events: the person may withdraw consent and thereby terminate the suspension; the suspension also ends on other prescribed events (consenting to being dealt with under s 7D, the Drug Court referring the matter back under s 7D, or the person being dealt with under s 7E) (s 8(2)(a)-(d)). These provisions create exit points from the procedural modification.

Eligibility thresholds as rights or exclusions:

• The Regulation prescribes conditions that persons must satisfy to be an eligible person (s 4) or an eligible convicted offender (s 5). Satisfying these conditions creates the right to be considered under the Act’s program pathways; failing to satisfy them excludes the person from the prescribed eligibility category. The eligible convicted offender category includes a sex requirement , the person must be male (s 5(d)). The local government area criteria require either usual residence in, or in the case of convicted offenders the means to reside within, a named LGA (s 4(a); s 5(a)).

Procedural form and fee equivalence:

• The Regulation allows the Drug Court to use the same forms and levy the same fees as the District and Local Courts for the Drug Court’s exercise of criminal jurisdiction (s 11; s 12(1)). This creates parity in administrative form and fee structures. At the same time the Drug Court retains the power to postpone, waive or remit fees, and delegates that capacity to the registrar (s 12(2)-(3)).

Communication modalities:

• The Regulation establishes permissible communication channels for referrals, notifications and provision of information: telephone, post, document exchange facilities, facsimile (broadly defined) and personal delivery (s 10(2)(a); s 13; s 14(2)). Those channels set a duty to use prescribed methods and confer on the registrar the power to require or waive written confirmations.

Allocation and availability duties:

• Facilities are "taken to be available" only where provider willingness, reasonable likelihood of availability when needed, and registrar receipt of advice about proposed treatment are all present (s 7(1)(a)(i)-(iii)). Providers and the registrar must therefore coordinate to satisfy these preconditions.

Savings:

• The savings clause (s 15) imposes a duty on officials to treat existing acts and arrangements that had effect under the repealed Regulation as continuing under this Regulation, preserving continuity.

In practical terms the Regulation sets out who must do what, by when and how: providers supply information and confirm oral communications; registrars accept referrals and may exercise fee powers; Drug Court sets allocation policy; referring courts notify the registrar using prescribed channels; and charged persons may consent to temporary suspension of certain procedural obligations. Legal and administrative actors must therefore build operational processes that reflect these duties and rights as stated in the Regulation.

The Regulation itself contains no express standalone penalty provisions or criminal offences; instead it prescribes procedures, duties and discretions that interact with the underlying statutory framework of the Drug Court Act 1998 and the Criminal Procedure Act 1986. The text supplied does not create new criminal sanctions or administrative penalties, and it does not specify enforcement sanctions for failure to comply with the technical requirements in the Regulation. The enforcement picture must therefore be read as follows, strictly grounded in the Regulation’s text.

Compliance channels and administrative levers:

• Registrar and Drug Court discretions operate as the primary enforcement mechanism. For example, allocation of facilities is governed by policies determined by the Drug Court (s 7(1)(b)). The court can withhold allocation by not including a facility within its policy or by finding the availability criteria unmet (s 7(1)(a)). These are functional controls rather than punishments; non‑compliance by a treatment provider with availability requirements will affect whether the provider is taken to have an available place for allocation.
• Fee powers can be used to enforce or relieve financial obligations. Although the Regulation permits fees consistent with District and Local Courts (s 12(1)), it simultaneously grants the Drug Court,and the registrar power to exercise the Drug Court’s function,the discretion to postpone, waive or remit those fees (s 12(2)-(3)). That discretionary financial power is an administrative enforcement tool.

Procedural consequences tied to consent:

• The Regulation modifies obligations under s 265(1) and (2) of the Criminal Procedure Act 1986 for Drug Court proceedings under certain sections of the Act where the person charged consents (s 8(1)). The effect is procedural: where consent is given, obligations of the Drug Court and the prosecutor under those Criminal Procedure Act provisions are suspended until specified events (s 8(2)(a)-(d)). The Regulation therefore creates a consent‑based procedural change rather than a punitive sanction. The listed cessation events are the mechanism that ends that suspension.

Information confirmation requirement:

• Providers of treatment and health services must confirm non‑written information in writing within 24 hours unless the registrar indicates otherwise (s 10(2)(b)). Failure to do so is not accompanied in the Regulation by an express penalty; however, practical consequences include the registrar potentially treating the information as not properly received for the purposes of decisions such as eligibility or facility allocation.

Referral mechanics:

• The Regulation prescribes channels for referrals to the Drug Court and for the registrar to notify referring courts (s 13; s 14(2)). Failure to comply with those channel requirements would not, under the Regulation itself, automatically create a statutory penalty but could have procedural consequences such as the Drug Court not having been properly notified or registrarial delays affecting allocation decisions.

No express enforcement provisions:

• The absence of express penalties in this Regulation means enforcement of duties will rely on: (1) the underlying Act and other statutes for available remedies or consequences; (2) court procedural management powers; (3) administrative practice, for example refusal to act on improperly supplied or unconfirmed information; and (4) professional and contractual mechanisms governing treatment providers and health district personnel.

Implications for practitioners and administrators:

• Because the Regulation relies on administrative discretions (allocation policies, fee remissions) and procedural consequences rather than specific penalty clauses, the primary enforcement avenue is process control. Courts and registrars can control outcomes by acting or refusing to act where preconditions are not satisfied. Those controlling powers will be the practical enforcement levers. Where a party believes that a registrar or the Drug Court has failed to perform a required function under the Act or this Regulation, remedies will need to be sought under the Act, the general supervisory jurisdiction of superior courts, or by reference to other applicable statutes; the Regulation itself does not spell out that remedial route.

In summary, enforcement under the Regulation is administrative and procedural rather than penal as far as this text shows. The principal sanctioning effects are operational: allocation decisions, continuation or cessation of modified procedural obligations, admission or rejection of information for registrarial purposes, and exercise of fee powers by the Drug Court or registrar (s 7; s 8; s 10; s 12). Practitioners should therefore focus on process compliance to manage risks arising from non‑performance or miscommunication.

The Regulation expressly references the Drug Court Act 1998 and the Criminal Procedure Act 1986 and situates itself as subordinate legislation operating to give effect to elements of those Acts. It also notes that the Interpretation Act 1987 and the Drug Court Act contain definitions and other provisions that affect interpretation and application of the Regulation (s 3(1) and associated note). The interaction points in the text supplied are the following.

Primary statutory embedding:

• The Regulation is made under and for the purposes of the Drug Court Act 1998. It prescribes criteria and processes that the Act refers to,most notably, the criteria for an "eligible person" under section 5(1)(e) of the Act and for an "eligible convicted offender" under section 5A(1)(f) of the Act (s 4; s 5). Thus the Regulation operationalises statutory hooks in the Act.

Modification of Criminal Procedure Act provisions:

• For specified Drug Court proceedings (those under sections 7A, 7B or 7C of the Act) the Regulation modifies the application of sections 265(1) and (2) of the Criminal Procedure Act 1986 by providing that the obligations of the Drug Court and the prosecutor under those provisions are suspended while the person charged consents to their suspension (s 8(1)). The suspension ceases on prescribed events (s 8(2)). This is the clearest instance where the Regulation changes the application of another Act’s procedural obligations in a narrowly defined circumstance. The Regulation thereby creates a consent‑based exception to operation of those Criminal Procedure Act obligations in Drug Court proceedings.

Forms and fees parity:

• The Regulation allows forms and fees used in the District Court and the Local Court to be used in the Drug Court when it exercises the criminal jurisdiction of the respective court (s 11; s 12(1)). This creates an administrative equivalence between the Drug Court acting in its criminal jurisdiction and the District/Local Courts for form and fee purposes; practitioners should read the Regulation together with any fee schedules and forms prescribed under the District and Local Courts’ regimes.

Interpretation Act and other definitions:

• The Regulation reminds readers that the Drug Court Act and the Interpretation Act 1987 contain definitions and provisions that affect interpretation, emphasising that the Regulation does not stand alone and must be read in statutory context (s 3(1) note). The Regulation’s own definition of facsimile expands the understanding of acceptable communication methods under its own provisions and may interact with electronic service and evidence rules in other statutes.

Health service and forensic science agencies:

• The Regulation prescribes specified health district personnel and the Drug Toxicology Unit of the NSW Forensic and Analytical Science Service as persons authorised to provide information to the Drug Court in connection with a drug offender’s program (s 10(1)(a)-(b)). This links the Drug Court’s procedural framework to the administrative functions of public health bodies and forensic services. Agencies providing services in connection with a program are drawn into registrarial information flows and confirmation duties (s 10).

Savings and transitional continuity:

• The savings provision preserves acts, matters and things that had effect under the repealed 2015 Regulation so that existing arrangements continue under this Regulation (s 15). This statutory continuity minimises immediate legal discontinuity between the two regulatory instruments.

Practical cross‑statutory consequences:

• Because the Regulation modifies the operation of specific Criminal Procedure Act obligations in the defined Drug Court context only with consent, practitioners must coordinate procedural strategy across statutes. For example, if a charged person consents to the suspension provided for in s 8(1), obligations under the Criminal Procedure Act will be temporarily displaced; the Regulation lists the events that revive those obligations (s 8(2)). The wider legislative framework, including rights and procedural protections in the Criminal Procedure Act and the Drug Court Act, remains the governing law outside that consented suspension.

Limitations of the text provided:

• The Regulation does not attempt to reproduce or restate the content of the Criminal Procedure Act provisions it modifies; it only prescribes the suspension mechanism in the limited circumstances specified (s 8). Therefore, to understand the full legal effect of the suspension and its interaction with other procedural safeguards, readers must read the Criminal Procedure Act provisions alongside this Regulation.

In short, the Regulation is tightly integrated with the Drug Court Act in setting eligibility, procedure and administrative rules, creates a narrowly tailored modification of obligations under the Criminal Procedure Act where consent is given, and imports District/Local Court forms and fees into the Drug Court context while notifying that interpretation and other definitions remain impacted by the broader statutory framework (s 3; s 4; s 5; s 8; s 11; s 12).

The Regulation’s text includes explicit amendment annotations for several provisions, indicating incremental changes across years. The supplied instrument also includes a commencement note that the Regulation replaces the Drug Court Regulation 2015 and that the repeal of the 2015 instrument occurred on 1 September 2020 under the Subordinate Legislation Act 1989 (s 2 note). The following chronology is recorded within the Regulation’s own marginalia.

• Commencement and replacement: The Regulation commences on the day of publication on the NSW legislation website and replaces the Drug Court Regulation 2015, which was repealed on 1 September 2020 by section 10(2) of the Subordinate Legislation Act 1989 (s 2 note).

• Section 4 amendments: The eligibility criteria in s 4 carry amendment citations: Am 2022 (606), sec 3(1); 2023 (440), sec 3; 2024 (44), Sch 1[1]. These notes indicate that the list of local government areas and/or the precise wording of eligibility was amended in 2022, 2023 and 2024. The Regulation text as supplied shows the current lists and thresholds but the marginalia record multiple amendments across those years.

• Section 5 amendment: Section 5’s marginal note records an amendment in 2026: Am 2026 (112), Sch 1[1]-[4]. The insertion of that note indicates that the eligible convicted offender criteria, including the male requirement and the local government area list in s 5, were amended or substituted in 2026.

• Section 6 amendment: Section 6 contains an amendment note Am 2022 (606), sec 3(2) (3), indicating changes to the referring courts list or to the scope of proceedings in 2022.

• Section 7 amendment: The guidelines provision in s 7 shows an amendment note Am 2022 (606), sec 3(4), reflecting a 2022 change to the availability/allocation rules or their drafting.

• Section 8 amendment: The Criminal Procedure Act interaction in s 8 has an amendment note Am 2022 (606), sec 3(5), indicating a 2022 modification to the suspension mechanism or its drafting.

• Section 9 substitution: Section 9, prescribing referring courts for eligible convicted offenders, shows a substitution (Subst 2026 (112), Sch 1[5]), indicating the entire section was substituted in 2026.

• Section 10 amendments: The provision on information to the Drug Court bears amendment notes Am 2022 (606), sec 3(6); 2024 (44), Sch 1[2], signalling changes in 2022 and 2024 to the list of prescribed persons or the communication methods and confirmation rules.

• Section 12 amendment: The fees provision includes Am 2022 (606), sec 3(7), showing a 2022 amendment, possibly clarifying the exercise of fee powers and the registrar’s delegated authority.

• Section 15 savings: No amendment note is attached, but the savings provision operates to carry forward effect of the 2015 Regulation.

These marginal notes indicate regular iterative updates to the Regulation’s eligibility lists, referring court lists and administration rules from 2022 through 2026. Practitioners should therefore treat the Regulation as an instrument subject to recent and potentially continuing amendments; the statutory marginalia within the instrument are the source’s record of alteration dates and specific schedules. The Regulation’s own commencement note records the repeal of the 2015 Regulation and provides a statutory anchor for the present text.

Because the supplied Regulation text contains amendment references, users should cross‑check the current consolidated version on the NSW legislation website for any further amendments after the dates noted in the marginalia. The Regulation preserves transitional continuity for actions that had effect under the repealed 2015 Regulation (s 15), which may be relevant for matters that began before the 2020 instrument took effect.

The Regulation as supplied does not record any case law, judgments, or litigation history interpreting its provisions. No decisions, appeals or judicial interpretations are cited in the text. The instrument contains only its own provisions, explanatory notes about commencement and amendment marginalia. Therefore the Regulation itself provides no direct precedential material or litigation history to cite.

Implications of the absence of recorded litigation in the Regulation:

• Legal uncertainty points. The absence of recorded judicial interpretation means certain elements of the Regulation that raise interpretive questions have not been authoritatively resolved in the text supplied. Examples include: the scope of the registrar’s discretion when confirming or waiving confirmation of oral communications (s 10(2)(b)), the practical boundaries of the Drug Court’s facility allocation policies (s 7(1)(b)), and the application of the consent‑based suspension of Criminal Procedure Act obligations (s 8(1)-(2)) in contested factual scenarios. Because no cases are recorded, practitioners must assume these issues remain open to judicial interpretation unless and until authoritative decisions are handed down.
• Areas likely to generate litigation. The Regulation creates several concrete decision points where litigation could arise, although the supplied text does not record such litigation. These include disputes over eligibility (particularly where residence or the "means to reside" are contested under s 4(a) and s 5(a)), sex‑based eligibility under s 5(d) for eligible convicted offenders, disagreements about whether a facility meets the availability criteria in s 7(1)(a), and procedural challenges to the validity or effect of a charged person’s consent to suspension of Criminal Procedure Act obligations under s 8. The Regulation’s treatment of certain communications as facsimile and the confirmation obligations under s 10(2) may also give rise to disputes about whether information was properly received.
• Reliance on statutory framework. In the absence of litigation, courts and practitioners will rely on the plain statutory text and on interpretive rules found in the Interpretation Act 1987 and the Drug Court Act. The Regulation itself reminds readers that those Acts contain definitions and interpretive provisions that will affect application of the Regulation (s 3(1) note). Therefore initial legal argumentation about the Regulation’s application will likely be statutory and textual in character.

Practical recommendations given the absence of cited litigation:

• Conservative practice: until contested points are clarified by case law, administrative actors (registrars, treatment providers, courts) should adopt conservative processes that err on meeting the Regulation’s formal requirements,for example, confirming oral communications in writing within the prescribed 24 hours unless the registrar clearly indicates otherwise (s 10(2)(b)); documenting provider willingness and registrar receipt of treatment advice as part of facility availability checks (s 7(1)(a)); and recording any consent under s 8 in a way that preserves written evidence of the consent and of any withdrawal.
• Monitor developments: because amendment marginalia show recent changes (2022-2026) and the Regulation creates operationally significant discretions, practitioners should watch for judicial decisions and administrative guidance that interpret the Regulation’s provisions and should review consolidated versions on the NSW legislation website.

In summary, there is no litigation history provided in the Regulation text; the instrument itself does not list cases. The likely areas for future litigation are determinable from the Regulation’s operational points of contact with fact and discretion, but until courts rule the lawfulness and proper application of specific provisions will be governed by statutory text and the broader legislative context.

The Regulation contains several technical features that create traps for the unwary practitioner or administrator. These "gotchas" arise from drafting choices, diverging eligibility lists, procedural confirmation timings, delegation of fee powers, and the registrar’s centralised role. Each item below points to the specific provision.

Residence and geographic lists differ across pathways

• The list of local government areas in s 4 (eligible person) is not identical to the list in s 5 (eligible convicted offender). Practitioners must check both lists because a person who qualifies as an eligible person under s 4 by residence may not meet s 5’s requirements after conviction, and vice versa (s 4(a); s 5(a)). Mistaking one list for the other will lead to incorrect eligibility assessments.

Sex‑based eligibility for convicted offenders

• Section 5 requires an eligible convicted offender to be male (s 5(d)). That sex‑based criterion applies only to the eligible convicted offender category; it does not appear in the eligible person provision under s 4. Failure to note this will lead to incorrect referrals post‑conviction and create procedural complications.

"Means to reside" language for convicted offenders

• Section 5(a) permits an eligible convicted offender to either have usual residence in, or "have the means to reside, within" a named local government area (s 5(a)). The phrase "means to reside" is a factual threshold that will require evidentiary proof and decision‑making by the court or registrar. Practitioners should gather and document evidence of accommodation means before relying on this criterion.

Facsimile definition broadens permitted communication modes

• The Regulation’s definition of facsimile explicitly includes the Internet and other electronic transmission methods from which written material can be reproduced (s 3(1)). While this is expansive and permits modern electronic workflows, it also imposes risks if parties treat casual electronic messages as satisfying formal delivery requirements without ensuring reproducibility and traceability under the facsimile definition.

Short confirmation window for oral information

• Information provided to the registrar otherwise than in writing must be confirmed in writing within 24 hours unless the registrar indicates otherwise (s 10(2)(b)). The 24‑hour deadline is short. Treatment providers and health district staff will need internal procedures to ensure timely written confirmation, or obtain a registrar indication that confirmation is not required.

Registrar’s delegated fee remission power

• The Drug Court may postpone, waive or remit fees and may delegate that function to the registrar (s 12(2)-(3)). This delegation centralises financial discretion. Parties should not assume that fee remission is only for judicial consideration; registrars can exercise this administrative power, potentially subject to local policy. Requesting fee relief through the registrar is therefore a distinct step.

Allocation subject to Drug Court policy

• Facilities considered available must still be allocated "in accordance with policies determined from time to time by the Drug Court" (s 7(1)(b)). Even if a facility meets the "available" criteria, allocation is not automatic; court policy governs prioritisation. Service providers and advocates should therefore engage with Drug Court policy frameworks to understand allocation likelihood.

Referral and referral‑back communication modes

• Referrals to the Drug Court must be made by telephone, in writing or by facsimile (s 13), and the registrar may notify a referring court of a referral back by telephone or facsimile (s 14(2)). Relying on informal electronic channels outside those three methods without confirming their equivalence under the facsimile definition may risk defective referral notice.

Referral back in absence of the person

• The Drug Court may refer a matter back to the referring court in the absence of the person to whom the order relates (s 14(1)). This permits procedure to advance without the person physically present; defence counsel should not assume that a client’s absence prevents a referral being made.

No express penalty for failure to confirm or for misreferral

• The Regulation does not establish fines or criminal sanctions for failing to comply with confirmation or referral procedures (s 10; s 13). Nevertheless, failures will have procedural consequences, such as non‑admission of information or delay in facility allocation. Parties should therefore treat process faults as operationally consequential even if not explicitly penalised.

Savings preserves prior arrangements

• Section 15 preserves any act, matter or thing that had effect under the repealed 2015 Regulation (s 15). Administrators must check historical arrangements to ensure continuity, because practices assumed to be obsolete might in fact continue to have effect under the savings clause.

Consent suspension mechanics require precise documentation

• The suspension of Criminal Procedure Act obligations under s 8(1) occurs only if the person charged consents. The Regulation makes no provision for implied or oral consent without documentation. Given the consequences of a suspension, parties should ensure consent is clearly recorded and that withdrawal or cessation events are also documented.

Taken together, these gotchas point to the need for careful procedural hygiene: check the correct eligibility list for the relevant pathway; document residence or means to reside; record consents and confirmations within the specified timeframes; treat the registrar as a decision point for fee remission and for written confirmation waivers; and ensure consistent use of approved communication channels under the facsimile definition.

Compliance with the Regulation requires operational steps mapped to the duties and processes the instrument prescribes. The following checklist is organised by actor and tied to the specific provisions that create obligations or procedural options.

For defence practitioners advising clients:

• Check eligibility early. Confirm the client’s usual place of residence against the precise lists in s 4(a) (eligible person) and s 5(a) (eligible convicted offender). Do not assume the lists are identical. If the client is a convicted offender, confirm whether they "have the means to reside" within a named local government area and document supporting evidence (s 5(a)).
• Verify age and jurisdictional exclusions. Ensure the client is at least 18 for both pathways (s 4(c); s 5(b)) and that the matter is not one within the Children’s Court jurisdiction (s 4(d); s 5(c)).
• Advise on mental condition threshold. For referrals under s 4, confirm whether any mental condition could prevent or restrict active participation in a program (s 4(b)). Where there is a potential incapacity issue, arrange assessments and document findings.
• Secure and document any consent under s 8. If the client is to consent to the suspension of obligations under parts of the Criminal Procedure Act, obtain informed written consent and record the scope and timing of that consent and any conditions, because the suspension applies only on consent and ends on withdrawal or on specified events (s 8(1); s 8(2)).

For referring courts and registrars:

• Use prescribed referral channels. Make referrals to the Drug Court by notifying the registrar by telephone, in writing or by facsimile (s 13). Maintain dated, time‑stamped records of telephone referrals and facsimile transmissions to avoid later disputes.
• Document facility availability evidence. If a referring court or registrar assesses facility availability, record provider willingness, reasons if availability is "reasonably likely" at the needed time, and the registrar’s receipt of advice on proposed treatment (s 7(1)(a)(i)-(iii)).
• Follow s 10(2) confirmation rule. When receiving information not provided in writing, ensure the 24‑hour written confirmation is sought or that the registrar indicates otherwise in writing (s 10(2)(b)). Implement administrative procedures that flag oral communications and trigger written confirmation workflows.
• Exercise fee discretions consistently. If the Drug Court or registrar is to postpone, waive or remit fees, apply and record consistent criteria and conditions for waiver decisions (s 12(2)-(3)). Keep auditable records of why relief was granted or refused.

For treatment providers and health district personnel:

• Confirm involvement threshold. Provide information to the Drug Court only if involved in the administration of, or providing services in connection with, a drug offender’s program (s 10(1)). Maintain documentation of the nature of the involvement.
• Use permitted communication methods and confirm oral communications. Provide information personally, by post, by document exchange facilities, or by message sent by facsimile as defined (s 10(2)(a)). If you supply oral information, confirm it in writing within 24 hours unless the registrar indicates otherwise (s 10(2)(b)). Build internal processes for same‑day or next‑day confirmations.
• Prepare treatment advice for registrars. Where facilities must be shown as "available", ensure timely delivery of treatment proposals to the registrar so the registrar can rely on that advice for availability determinations (s 7(1)(a)(iii)).

For Drug Court administrators and judges:

• Publish and apply allocation policies. The Drug Court must determine facility allocation policies from time to time (s 7(1)(b)). Draft, publish internally, and apply policies that explain priority rules, eligibility cross‑checks and contingencies when supply is constrained.
• Decide and record referrals back. If referring a matter back under s 7D of the Act, be aware the Drug Court may do so without the person being present and ensure registrarial notification to the referring court by telephone or facsimile is recorded (s 14(1)-(2)).
• Use forms and fees consistently. Apply District Court and Local Court forms and fee structures where the Drug Court exercises criminal jurisdiction (s 11; s 12(1)), and ensure that registrarial decisions about fee postponement, waiver or remission are grounded in transparent administrative practice (s 12(2)-(3)).

For prosecutors:

• Be prepared for procedural suspension on consent. If a charged person consents under s 8(1), the prosecutor’s obligations under specified Criminal Procedure Act provisions are suspended. Coordinate with the court and defence to document consent precisely and monitor for withdrawal or cessation events listed in s 8(2).
• Engage with registrars about confirmations. If providing information about a drug offender’s program, follow the confirmation timelines in s 10(2) and liaise with treatment providers to ensure timely written corroboration.

Operational and record‑keeping steps for all actors:

• Centralise registrar communications. Because the registrar is the hub for referrals, confirmations and fee remission decisions (s 10; s 12; s 13), create a single registrar contact point with logged telephone lines, a dedicated facsimile or defined electronic facsimile workflow consistent with the Regulation’s facsimile definition (s 3(1)), and a document exchange procedure.
• Maintain auditable evidence for eligibility. Keep records establishing residence, means to reside, age, mental capacity to participate in a program, and any consents or withdrawals under s 8.
• Review current consolidated text. The Regulation has multiple recent amendments (marginal notes in s 4-s 12), so check the NSW legislation website for the consolidated and current instrument before advising clients or making administrative decisions (s 2 note; amendment marginalia).

Compliance is primarily about process fidelity: use the correct list for the right pathway, adopt permitted communication modes as defined, confirm oral information within the 24‑hour window unless waived, document consents and withdrawals precisely, and implement clear registrar protocols for fee remission, referral receipt and notification. These concrete steps map directly to the Regulation’s operative sections and will mitigate administrative error and procedural challenge.